There were 145 press releases posted in the last 24 hours and 357,575 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
SparingVision Reports Positive Initial Safety Data from the first cohort treated in its PRODYGY Phase I/II Gene Therapy Trial

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image